CLINICAL RESEARCH: HYPERTROPHIC CARDIOMYOPATHY
Mutations in Alpha-Actinin-2 Cause Hypertrophic CardiomyopathyA Genome-Wide Analysis
Christine Chiu, BSc*, ,
Richard D. Bagnall, PhD*,
Jodie Ingles, BBioMedSc*, ,
Laura Yeates, BSc*,
Marina Kennerson, PhD ,
Jennifer A. Donald, PhD ,
Mika Jormakka, PhD||,
Joanne M. Lind, PhD¶ and
Christopher Semsarian, MBBS, PhD*, ,#,*
* Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Newtown, Australia
Faculty of Medicine, University of Sydney, Sydney, Australia
ANZAC Research Institute, Sydney, Australia
Department of Biological Sciences, Macquarie University, Sydney, Australia
|| Structural Biology Unit, Centenary Institute, Newtown, Australia
¶ School of Medicine, University of Western Sydney, Parramatta, Australia
# Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
Manuscript received August 31, 2009;
revised manuscript received September 23, 2009,
accepted November 9, 2009.
* Reprint requests and correspondence: Prof. Christopher Semsarian, Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag 6, Newtown, NSW 2042, Australia (Email: c.semsarian{at}centenary.org.au).
Objectives: This study describes a genome-wide linkage analysis of a large family with clinically heterogeneous hypertrophic cardiomyopathy (HCM).
Background: Familial HCM is a disorder characterized by genetic heterogeneity. In as many as 50% of HCM cases, the genetic cause remains unknown, suggesting that other genes may be involved.
Methods: Clinical evaluation, including clinical history, physical examination, electrocardiography, and 2-dimensional echocardiography, was performed, and blood was collected from family members (n = 23) for deoxyribonucleic acid analysis. The family was genotyped with markers from the 10-cM AB PRISM Human Linkage mapping set (Applied Biosystems, Foster City, California), and 2-point linkage analysis was performed.
Results: Affected family members showed marked clinical diversity, ranging from asymptomatic individuals to those with syncope, heart failure, and premature sudden death. The disease locus for this family was mapped to chromosome 1q42.2-q43, near the marker D1S2850 (logarithm of odds ratio = 2.82, = 0). A missense mutation, Ala119Thr, in the alpha-actinin-2 (ACTN2) gene was identified that segregated with disease in the family. An additional 297 HCM probands were screened for mutations in the ACTN2 gene using high-resolution melt analysis. Three causative ACTN2 mutations, Thr495Met, Glu583Ala, and Glu628Gly, were identified in an additional 4 families (total 1.7%) with HCM.
Conclusions: This is the first genome-wide linkage analysis that shows mutations in ACTN2 cause HCM. Mutations in genes encoding Z-disk proteins account for a small but significant proportion of genotyped HCM families.
Key Words: -actinin-2 gene mutations hypertrophic cardiomyopathy
|
Abbreviations and Acronyms
| | ACTN2 = alpha-actinin-2 | | HCM = hypertrophic cardiomyopathy | | ICD = implantable cardioverter-defibrillator | | LOD = logarithm of odds ratio | | LVH = left ventricular hypertrophy | | PCR = polymerase chain reaction | | SR = spectrin-like repeat |
|
Related Articles
-
Z-Disc Genes in Hypertrophic Cardiomyopathy: Stretching the Cardiomyopathies?
- J. Martijn Bos and Michael J. Ackerman
J. Am. Coll. Cardiol. 2010 55: 1136-1138.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A27.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Elliott and S. A. Mohiddin
Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Heart,
December 1, 2011;
97(23):
1914 - 1919.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Olivotto, F. Girolami, R. Sciagra, M. J. Ackerman, B. Sotgia, J. M. Bos, S. Nistri, A. Sgalambro, C. Grifoni, F. Torricelli, et al.
Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations
J. Am. Coll. Cardiol.,
August 16, 2011;
58(8):
839 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Ackerman, S. G. Priori, S. Willems, C. Berul, R. Brugada, H. Calkins, A. J. Camm, P. T. Ellinor, M. Gollob, R. Hamilton, et al.
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Europace,
August 1, 2011;
13(8):
1077 - 1109.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y. W. Lew, J. A. C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2010
J. Am. Coll. Cardiol.,
January 25, 2011;
57(4):
480 - 514.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Leenders, W. J. Wijnen, M. Hiller, I. van der Made, V. Lentink, R. E. W. van Leeuwen, V. Herias, S. Pokharel, S. Heymans, L. J. de Windt, et al.
Regulation of Cardiac Gene Expression by KLF15, a Repressor of Myocardin Activity
J. Biol. Chem.,
August 27, 2010;
285(35):
27449 - 27456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Bos and M. J. Ackerman
Z-Disc Genes in Hypertrophic Cardiomyopathy: Stretching the Cardiomyopathies?
J. Am. Coll. Cardiol.,
March 16, 2010;
55(11):
1136 - 1138.
[Full Text]
[PDF]
|
 |
|
|